Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Human Gene Therapy
|
August 28, 2024
Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies
Angela E Araujo, Martin Bentler, Xabier Perez Garmendia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2022
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial
U T Hacker, D Hasenclever, R Baber, et al.
Genomics
|
October 15, 1996
The mouse X-linked developmental mutant, tattered, lies between DXMit55 and Xkh and is associated with hyperkeratinization
I C Uwechue, B F Cooper, C Goble, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
SAGA-a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma
B Kobitzsch, G Stocker, U T Hacker, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 30, 2019
Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial
Ulrich T Hacker, Dirk Hasenclever, Nicolas Linder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
Gertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
European Journal of Clinical Investigation
|
May 6, 1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms
U T Hacker, C Bidlingmaier, M Gomolka, et al.
International Journal of Sport Nutrition and Exercise Metabolism
|
January 11, 2000
Intravenous versus oral rehydration during a brief period: stress hormone responses to subsequent exhaustive exercise in the heat
D J Casa, C M Maresh, L E Armstrong, et al.
Cancer Investigation
|
December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer
Valentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
British Journal of Cancer
|
April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
Ulrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Human Gene Therapy
|
August 28, 2024
Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies
Angela E Araujo, Martin Bentler, Xabier Perez Garmendia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2022
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial
U T Hacker, D Hasenclever, R Baber, et al.
Genomics
|
October 15, 1996
The mouse X-linked developmental mutant, tattered, lies between DXMit55 and Xkh and is associated with hyperkeratinization
I C Uwechue, B F Cooper, C Goble, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
SAGA-a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma
B Kobitzsch, G Stocker, U T Hacker, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 30, 2019
Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial
Ulrich T Hacker, Dirk Hasenclever, Nicolas Linder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
Gertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
European Journal of Clinical Investigation
|
May 6, 1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms
U T Hacker, C Bidlingmaier, M Gomolka, et al.
International Journal of Sport Nutrition and Exercise Metabolism
|
January 11, 2000
Intravenous versus oral rehydration during a brief period: stress hormone responses to subsequent exhaustive exercise in the heat
D J Casa, C M Maresh, L E Armstrong, et al.
Cancer Investigation
|
December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer
Valentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
British Journal of Cancer
|
April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
Ulrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Page
of 7